Improving 5-Fluorouracil (5-FU) Continuous Infusion Comfort With a New Corset Design in People Affected by Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-04-10

Study Completion Date

2024-12-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This feasibility randomized controlled trial aims to evaluate the effectiveness and usability of a newly designed supportive corset for patients receiving continuous 5-Fluorouracil (5-FU) infusion therapy. The corset is intended to stabilize the infusion pump and serum set, reduce physical and psychological discomfort, and improve overall quality of life. Forty colorectal cancer patients were randomized into two groups: an intervention group using the corset and a control group receiving standard care. Outcomes include infusion-related experiences (measured by Visual Analog Scale) and quality of life (assessed by EORTC QLQ-C30).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluating Factors Affecting Survival in Colon and Rectum Cancer

NCT05388513

Colon Cancer Rectum Cancer

COMPLETED

Factors Affecting the Time to Start Postoperative Chemotherapy in Colorectal Cancer

NCT04885283

the Time to Start Postoperative Chemotherapy

COMPLETED

Immune Checkpoints in Predicting Response to Neoadjuvant Therapy in Rectal Cancer

NCT05457075

Rectal Cancer

COMPLETED

The Clinical Efficacy of Drug Sensitive Neoadjuvant Chemotherapy Based on Organoid Versus Traditional Neoadjuvant Chemotherapy in Advanced Rectal Cancer

NCT05352165

Neoadjuvant Therapy

NOT_YET_RECRUITING NA

Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery

NCT00960427

Colorectal Cancer

WITHDRAWN PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Continuous infusion of 5-Fluorouracil (5-FU) via portable pumps is a common treatment modality for colorectal cancer, offering clinical benefits such as stable plasma drug levels and improved tolerability. However, patients often experience physical discomfort, restricted mobility, sleep disturbances, anxiety, and aesthetic concerns related to the infusion pump. Technical issues such as unstable connections and medication flow interruptions may further compromise treatment safety.

To address these challenges, this study introduces a newly designed supportive corset aimed at stabilizing the infusion pump and serum set during continuous 5-FU therapy. The corset is designed to enhance comfort, reduce movement-related anxiety, and improve sleep quality and overall treatment experience. This feasibility trial enrolled 40 patients diagnosed with colorectal cancer from an outpatient chemotherapy unit in Türkiye. Participants were randomized into two groups: the intervention group received the corset in addition to standard care, while the control group received standard care only.

Data were collected at baseline and after four weeks using the Visual Analog Scale (VAS) for infusion-related experiences and the EORTC QLQ-C30 for quality of life. The primary outcomes include changes in physical restrictions, insomnia, anxiety during movement, aesthetic concerns, and overall quality of life. Secondary outcomes include patient satisfaction with the corset. The study was approved by the Clinical Research Ethics Committee (Approval No: 2023-19-09) and conducted in accordance with ethical standards. Findings will inform the feasibility and potential integration of supportive physical devices into cancer care protocols.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colorectal Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

This study is a parallel-group, randomized controlled feasibility trial designed to evaluate the effectiveness and usability of a newly developed supportive corset for patients receiving continuous 5-Fluorouracil (5-FU) infusion therapy. Forty colorectal cancer patients were randomly assigned to two groups: an intervention group using the corset in addition to standard care and a control group receiving standard care only. The intervention lasted four weeks, and outcomes were assessed at baseline and post-intervention using the Visual Analog Scale (VAS) for infusion-related experiences and the EORTC QLQ-C30 for quality of life.

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

This study is open-label; no masking was applied. Both participants and researchers were aware of group assignments because the intervention involved the use of a visible supportive corset during continuous 5-FU infusion therapy.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard of Care + Supportive Corset

Participants receive standard care plus a specially designed supportive corset during continuous 5-FU infusion.

Group Type EXPERIMENTAL

Supportive Corset

Intervention Type DEVICE

A specially designed supportive corset developed to stabilize the 5-FU infusion pump and serum set during continuous infusion therapy. It includes a body-wrapping belt, adjustable shoulder strap aligned with the port catheter, and a fluid-proof pouch for carrying the infusion pump. The corset aims to enhance comfort, reduce physical and psychological distress, and improve overall treatment experience.

Standard of Care

Participants receive routine care without any additional intervention.

Group Type OTHER

Standard care

Intervention Type OTHER

Routine care provided during continuous 5-FU infusion without any additional supportive device.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Supportive Corset

A specially designed supportive corset developed to stabilize the 5-FU infusion pump and serum set during continuous infusion therapy. It includes a body-wrapping belt, adjustable shoulder strap aligned with the port catheter, and a fluid-proof pouch for carrying the infusion pump. The corset aims to enhance comfort, reduce physical and psychological distress, and improve overall treatment experience.

Intervention Type DEVICE

Standard care

Routine care provided during continuous 5-FU infusion without any additional supportive device.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed with colorectal cancer
* Currently receiving chemotherapy
* Having received at least one cycle of 5-FU therapy via continuous infusion
* Volunteering to participate in the study
* Aged 18 years or older

Exclusion Criteria

* Diagnosis of brain cancer (excluded due to potential impact on cognitive function and reliability of self-reported data)
* Presence of bone metastases
* Pregnancy and/or lactation
* Communication barriers
* Physician-diagnosed mental illness
* Inability to speak or understand Turkish

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No